The 20 Best Squamous Cell Lung Carcinoma Doctors Near Me in Teaneck, NJ
Find the Top Squamous Cell Lung Carcinoma Experts and Specialists
The 20 Best Squamous Cell Lung Carcinoma Doctors near Teaneck, NJ
MediFind found 638 doctor with experience in Squamous Cell Lung Carcinoma near Teaneck, NJ. Of these, 463 are Experienced, 105 are Advanced, 66 are Distinguished and 4 are Elite.
HMH - Pulmonary Academic Practice
Keith Brenner is a Pulmonary Medicine provider in Hackensack, New Jersey. Dr. Brenner is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Metastases, Lung Nodules, Acute Interstitial Pneumonia, and Interstitial Lung Disease.
CUIMC/Herbert Irving Pavilion
Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gregory Riely is an Oncologist in New York, New York. Dr. Riely is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Thymic Epithelial Tumor, Tissue Biopsy, and Liver Embolization. Dr. Riely is currently accepting new patients.
Rockefeller Outpatient Pavilion
Valerie Rusch is a Thoracic Surgeon in New York, New York. Dr. Rusch is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Mesothelioma, Lung Cancer, Lung Adenocarcinoma, Tissue Biopsy, and Thymectomy.
HMH - John Theurer Cancer Center - Hackensack
Harry Harper is an Oncologist in Hackensack, New Jersey. Dr. Harper is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Gastrostomy, and Tissue Biopsy.
HMH - John Theurer Cancer Center - Hackensack
Martin Gutierrez is a Medical Genetics provider in Hackensack, New Jersey. Dr. Gutierrez is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Tissue Biopsy.
Pulmonary Specialists Of North Jersey
Paul Han is a Pulmonary Medicine provider in Englewood, New Jersey. Dr. Han is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Metastases, Chronic Cough, Pneumonia, Gastrostomy, and Pacemaker Implantation.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Paul Paik is an Oncologist in New York, New York. Dr. Paik is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Tissue Biopsy, and Gamma Knife Radiosurgery. Dr. Paik is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Mark Kris is an Oncologist in New York, New York. Dr. Kris is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Kris is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Joshua Sonett is a Thoracic Surgeon and a Transplant Surgeon in New York, New York. Dr. Sonett is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Thymectomy, and Endoscopy. Dr. Sonett is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Dr. Ebright joined Columbia University Irving Medical Center after serving on the faculty at Boston University School of Medicine for six years. There, he was Director of the Center for Thoracic Oncology and Co-Director of the Lung CyberKnife Program. At Columbia, he sees patients for thoracic surgery and serves as Vice Chair of Surgery at Stamford Hospital, a Columbia partner site in Connecticut.He has numerous publications in peer-reviewed journals and has authored book chapters on a variety of topics related to thoracic surgery. In addition, he has been selected as a Castle Connolly Top Doctor, as identified in Boston, New York and Connecticut magazines. Dr. Ebright is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Endoscopy, and Gastrostomy.
CUIMC/Herbert Irving Pavilion
Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Salpingo-Oophorectomy.
CUIMC/Herbert Irving Pavilion
Dr. Mark E. Ginsburg is an associate Professor of Surgery at Columbia University Medical Center and surgical director of the Diaphragm Program and the Lung Volume Reduction program. Dr. Ginsburg received his MD from Tufts University School of Medicine in 1980, completed his General Surgery residency in 1985 and Thoracic and Cardiovascular Residency in 1987 both at the University of Rochester Medical Center. He is renown for his surgical work in patients with disorders of the Diaphragm, and is one of few surgeons in the country to perform pacing of the diaphragm. Dr. Ginsburg has lectured and published extensively on this subject, and recently addressed the 95th AATS Annual Meeting in 2015, presenting ten-year data on lung volume reduction surgery (LVRS). The results, based primarily on surgical experience in the Division of Thoracic Surgery at New York-Presbyterian/Columbia, showed durable benefits that should promote wider adoption of LVRS in patients with severe emphysema. Dr. Ginsburg has been an invited speaker and principal and co-investigator of numerous clinical trials, author of numerous publications in renown journals such as the Journal of The American College of Cardiology, Annals of Thoracic Surgery, and the Journal of Heart and Lung Transplant, among many others, including co-author of the book, Lung Volume Reduction Surgery published by Humana Press. He’s also currently on the department of surgery QA committee and is a member of numerous professional societies including, the American College of Surgeons, New York State Medical Society, New York Society of Thoracic Surgeons, the Society of Thoracic Surgeons and the International Society for Heart and Lung Transplantation. Dr. Ginsburg is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Advanced Bronchoscopy, and Thymectomy.
CUIMC/Herbert Irving Pavilion
Dr. Oommen comes to NYP from Boston, where he served as a thoracic surgery attending at Boston Medical Center and at Thoracic Surgery Associates. Dr. Oommen’s training included a joint MBA and medical degree at Howard University in 2004; general surgery residency at New York Medical College; cardiothoracic surgery residency at Montefiore-Albert Einstein College of Medicine; and minimally invasive thoracic surgery fellowship at Boston Medical Center.In addition to his professional duties, Dr. Oommen volunteers as Medical Director for the non-profit organization Love Without Reason. Dr. Oommen is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Gastrostomy.
Byron Thomashow is a Pulmonary Medicine provider in New York, New York. Dr. Thomashow is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, and Emphysema.
HMH - John Theurer Cancer Center - Hackensack
Brett Lewis is a Radiation Oncologist in Hackensack, New Jersey. Dr. Lewis is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Small Cell Lung Cancer (SCLC).
HMH - John Theurer Cancer Center - Hackensack
Anthony Ingenito is a Radiation Oncologist in Hackensack, New Jersey. Dr. Ingenito is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Embryonal Tumor with Multilayered Rosettes.
HMH - John Theurer Cancer Center - Hackensack
Tracy Proverbs is an Oncologist in Hackensack, New Jersey. Dr. Proverbs is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, Endoscopy, and Gastrostomy.
HMH - John Theurer Cancer Center - Hackensack
Mark Pascal is a Hematologist in Hackensack, New Jersey. Dr. Pascal is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.
Englewood Health Physician Network-Hematology Oncology Physicians Of Englewood
Lewis Attas is an Oncologist in Englewood, New Jersey. Dr. Attas has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Last Updated: 02/22/2026









